Boughton Soleil 4

What Happened

• Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc. (HIMS), sold 4,812 shares of HIMS stock on March 17, 2026. The shares were sold at $24.69 each for total proceeds of approximately $118,808. This was a sale (not a purchase), which is often routine insider selling rather than a direct bullish signal.

Key Details

• Transaction date and price: March 17, 2026 — 4,812 shares sold at $24.69 per share.
• Total value: ~ $118,808.
• Shares owned after transaction: Not provided in the information supplied.
• Footnote: The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025 (pre-arranged trading plan).
• Filing timeliness: Reported on March 18, 2026 for a March 17, 2026 transaction — appears timely.

Context

• Trades under a Rule 10b5-1 plan are pre-scheduled and can reflect previously arranged instructions rather than contemporaneous insider views. Sales are common for liquidity or diversification and do not necessarily indicate management’s view of company prospects.